Veeda Oncology

Academic / Other · 9 registered clinical trials.

Status	Trial	Phase	Started
Terminated	A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast Breast Cancer	Phase 2	2007-09-01
Terminated	A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiti Nausea and Vomiting	Phase 4	2006-08-01
Terminated	PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC Hormone Refractory Prostate Cancer	Phase 2	2006-04-01
Completed	A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC Non-Small Cell Lung Cancer	Phase 2	2005-11-01
Completed	A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lun Non-Small Cell Lung Cancer	Phase 2	2005-10-01
Completed	A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Canc Metastatic Breast Cancer	Phase 2	2005-03-01
Terminated	A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome Myelodysplastic Syndrome	Phase 2	2004-08-01
Completed	A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer Colorectal Cancer	Phase 2	2004-03-01
Completed	Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Carcinoma, Non-Small-Cell Lung	Phase 2	—